Evidence-Based Reviews

‘I’m sober, Doctor, really’: Best biomarkers for underreported alcohol use

Current Psychiatry. 2008 September;7(9):15-16,19-22,27

References

1. Allen JP, Anthenelli RM. Getting to the bottom of problem drinking: the case for routine screening. Current Psychiatry 2003;2(6):26-44.

2. Killeen TK, Brady KT, Gold PB, et al. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend 2004;73(2):141-7.

3. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it. Prescrire Int 2007;16(87):24-31.

4. Morgan MY, Colman JC, Sherlock S. The use of a combination of peripheral markers for diagnosing alcoholism and monitoring for continued abuse. Alcohol Alcohol 1981;16:167-77.

5. Hietala J, Koivisto H, Anttila P, et al. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006;41(5):528-33.

6. Swift R. Direct measurement of alcohol and its metabolites. Addiction 2003;98:73-80.

7. Koivisto H, Hietala J, Anttila P, et al. Long-term ethanol consumption and macrocytosis: diagnostic and pathogenic implications. J Lab Clin Med 2005;147(4):191-6.

8. Savage DG, Ogundipe A, Allen RH, et al. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 2000;319(6):343-52.

9. Gordon H. Detection of alcoholic liver disease. World J Gastroenterol 2001;7(3):297-302.

10. Bernadt M, Mumford J, Taylor C, et al. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet 1982;1:325-8.

11. Hasselblatt M, Martin F, Maul O, et al. Persistent macrocytosis following abstinence from chronic alcohol use. JAMA 2001;286:2946.-

12. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-9.

13. Fancher T, Kamboj A, Onate J. Interpreting liver function tests. Current Psychiatry 2007;6(5):61-8.

14. Puukka K, Hietala J, Koivisto H, et al. Obesity and the clinical use of serum GGT activity as a marker of heavy drinking. Scand J Clin Lab Invest 2007;67(5):480-8.

15. Litten RZ, Allen JP, Fertig JB. y-glutamyl transpeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption. Alcohol Clin Exp Res 1995;19(6):1541-6.

16. National Institute on Alcohol Abuse and Alcoholism. Screening for alcohol problems—an update. Alcohol Alert No 56 Available at: http://pubs.niaaa.nih.gov/publications/aa56.htm. Accessed May 5, 2007.

17. DiMartini A. A clinical guide to assessing alcohol use and problems. Available at: http://www.alcoholmedicalscholars.org/clin-asmt.ppt. Accessed June 30, 2008.

18. Wolff K, Marshall E. Biological markers of alcohol use. Psychiatry 2006;5(12):437-8.

19. ARUP Laboratories. Carbohydrate-deficient transferrin (CDT) for alcohol use. 2006. Available at: http://www.aruplab.com/TestDirectory/resources/TechnicalBulletins/Carbohydrate-Deficient%20Transferrin%20(CDT)%20Mar%202006.pdf. Accessed July 30, 2008.

20. Allen JP, Litten RZ. The role of laboratory testing in alcoholism treatment. J Subst Abuse Treat 2001;20:81-5.

21. Bhushan V, Le T, Ozturk A, et al. Behavioral Science. In: Le T, Bhushan V, Rao DA, eds. First aid for the USMLE step 1: a student to student guide. New York, NY: McGraw Hill Medical Publishing Division; 2007.

22. Miller PM, Anton RF. Biochemical alcohol screening in primary care. Addict Behav 2004;29(7):1427-37.

23. Schmidt LG, Schmidt K, Dufeu P, et al. Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism. Am J Psychiatry 1997;154(1):75-80.

24. Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 1999;19(3):261-71.

25. Dolman JM, Hawkes ND. Combining the AUDIT questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical patients. Alcohol Alcohol 2005;40(6):515-9.

26. Helander A, Carlsson AV, Borg S. Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: complementary markers of excessive alcohol consumption. Alcohol Alcohol 1996;31(1):101-7.

27. Gluud C, Andersen I, Dietrichson O, et al. Gamma-glutamyltransferase, aspartate aminotransferase and alkaline phosphatase as markers of alcohol consumption in out-patient alcoholics. Eur J Clin Invest 1981;11(3):171-6.

28. Kawachi I, Robinson GM, Stace NH. A combination of raised serum AST: ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption. N Z Med J 1990;103(887):145-8.

29. Mundle G, Ackerman K, Mann K. Biological markers as indicators for relapse in alcohol-dependent patients. Addict Biol 1999;4(2):209-14.

30. Bell H, Tallaksen C, Sjåheim T, et al. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol Clin Exp Res 1993;17(2):246-52.

31. Sillanaukee P, Aalto M, Seppa K. Carbohydrate-deficient transferrin and conventional alcohol markers as indicators for brief intervention among heavy drinkers in primary health care. Alcohol Clin Exp Res 1998;22(4):892-6.

32. Salaspuro S. Conventional and coming laboratory markers of alcoholism and heavy drinking. Alcohol Clin Exp Res 1986;10(6 suppl):5-12.

33. Della Penna ND, Treisman GJ. HIV/AIDS. In: Levenson J, ed. Essentials of psychosomatic medicine. Washington, DC: American Psychiatric Publishing, Inc; 2007.